De novo biosynthesis of 2-phenylacetamide in engineered Escherichia coli-Reference-Cited by-同舟云学术

De novo biosynthesis of 2-phenylacetamide in engineered Escherichia coli

Published:2023-05 Issue: Volume:194 Page:108882
ISSN:1369-703X
Container-title:Biochemical Engineering Journal
language:en
Short-container-title:Biochemical Engineering Journal

Author:

Hu Chunyue,Wu Shaoting,Pan Hong,Guo Daoyi

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Publisher

Elsevier BV

Subject

Biomedical Engineering,Environmental Engineering,Bioengineering,Biotechnology

Reference43 articles.

1. Solubility behavior of 2-phenylacetamide in sixteen pure solvents and dissolution properties of solution;Li;J. Mol. Liq.,2019

2. Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis;Cumming;Bioorg. Med. Chem. Lett.,2012

3. In-vitro cytotoxicity screening of 2-(2, 3-dioxo-2, 3-dihydro-1H-indol-1-yl)-N-phenylacetamide derivatives for anti-lung and anti-breast cancer activity;Sukhramani;J. Pharm. Res.,2011

4. Fungicidal activities of cyflufenamid against various plant-pathogenic fungi;Haramoto;J. Pestic. Sci.,2006

5. Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide—a potential antileishmanial agent;Sahu;Bioorg. Med. Chem.,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic engineering of Escherichia coli for production of acetaminophen from glucose based on high selectivity of N-acetyltransferase;Biochemical Engineering Journal;2024-03